Inventor
NIITSU YOSHIRO
JP36 patents
⚠️ This page may combine multiple inventors who share the name “NIITSU YOSHIRO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NITTO DENKO CORP
23 patentsUS9771582B2Sep 26, 2017
RNA interference compositions and methods for malignant tumors
NITTO DENKO CORP13 citations92
US9242001B2Jan 26, 2016
Cationic lipids for therapeutic agent delivery formulations
NITTO DENKO CORP14 citations92
US9206424B2Dec 8, 2015
Modulation of HSP47 expression
NITTO DENKO CORP21 citations92
US8003621B2Aug 23, 2011
Drug carriers
NITTO DENKO CORP33 citations91
US10100004B2Oct 16, 2018
Compounds for targeting drug delivery and enhancing siRNA activity
NITTO DENKO CORP4 citations84
US9456984B2Oct 4, 2016
Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier
NITTO DENKO CORP10 citations84
USRE48887EJan 11, 2022
RNA interference compositions and methods for malignant tumors
NITTO DENKO CORP2 citations83
US10196637B2Feb 5, 2019
Retinoid-lipid drug carrier
NITTO DENKO CORP7 citations83
US10093923B2Oct 9, 2018
Modulation of HSP47 expression
NITTO DENKO CORP5 citations83
US9963424B2May 8, 2018
Cationic lipids for therapeutic agent delivery formulations
NITTO DENKO CORP8 citations83
US8574623B2Nov 5, 2013
Therapeutic agent for pulmonary fibrosis
NITTO DENKO CORP8 citations79
US10195145B2Feb 5, 2019
Method for treating fibrosis using siRNA and a retinoid-lipid drug carrier
NITTO DENKO CORP4 citations73
US10000447B2Jun 19, 2018
Compounds for targeting drug delivery and enhancing siRNA activity
NITTO DENKO CORP2 citations73
US11084779B2Aug 10, 2021
Cationic lipids for therapeutic agent delivery formulations
NITTO DENKO CORP2 citations72
US9914983B2Mar 13, 2018
Apoptosis-inducing agent
NITTO DENKO CORP3 citations69
US10669229B2Jun 2, 2020
Compounds for targeting drug delivery and enhancing siRNA activity
NITTO DENKO CORP0 citations52
US10093931B2Oct 9, 2018
Apoptosis inducer
NITTO DENKO CORP0 citations52
US9572886B2Feb 21, 2017
Agent for treating myelofibrosis
NITTO DENKO CORP1 citations52
US10532975B2Jan 14, 2020
Cationic lipids for therapeutic agent delivery formulations
NITTO DENKO CORP0 citations51
US9976142B2May 22, 2018
Targeting molecule and a use thereof
NITTO DENKO CORP1 citations51
US10570396B2Feb 25, 2020
Cell death inducing agent for cells having BRAF gene mutation, growth suppressing agent for same cells and pharmaceutical composition for therapy of diseases caused by growth defect of same cells
NITTO DENKO CORP0 citations45
US9926561B2Mar 27, 2018
Composition for regenerating normal tissue from fibrotic tissue
NITTO DENKO CORP0 citations41
US10098953B2Oct 16, 2018
Therapeutic agent for fibroid lung
NITTO DENKO CORP0 citations39
NIITSU YOSHIRO
9 patentsUS8741867B2Jun 3, 2014
Retinoid-liposomes for treating fibrosis
NIITSU YOSHIRO34 citations93
US9393315B2Jul 19, 2016
Compounds for targeting drug delivery and enhancing siRNA activity
NIITSU YOSHIRO12 citations92
US9011903B2Apr 21, 2015
Cationic lipids for therapeutic agent delivery formulations
NIITSU YOSHIRO26 citations92
US8664376B2Mar 4, 2014
Retinoid-liposomes for enhancing modulation of HSP47 expression
NIITSU YOSHIRO30 citations92
US8178124B2May 15, 2012
Drug carrier and drug carrier kit for inhibiting fibrosis
NIITSU YOSHIRO20 citations92
US8173170B2May 8, 2012
Drug carrier and drug carrier kit for inhibiting fibrosis
NIITSU YOSHIRO32 citations92
US8686052B2Apr 1, 2014
Targeting agent for cancer cell or cancer-associated fibroblast
NIITSU YOSHIRO32 citations91
US8652526B2Feb 18, 2014
Drug carrier and drug carrier kit for inhibiting fibrosis
NIITSU YOSHIRO10 citations84
US9408864B2Aug 9, 2016
Composition for regenerating normal tissue from fibrotic tissue
NIITSU YOSHIRO0 citations41